Related Experiment Videos
Intrahepatic cholestatic syndromes: pathogenesis, clinical features and management.
1Division of Gastroenterology, Baylor College of Medicine and VAMC, Houston, Tex., USA.
Digestive Diseases (Basel, Switzerland)
|August 7, 1999
Summary
Intrahepatic cholestasis, a condition of reduced bile flow, involves bile buildup in the liver and blood. Treatment options include ursodeoxycholic acid, supportive care, and liver transplantation for advanced cases.
Area of Science:
- Hepatology
- Gastroenterology
Background:
- Intrahepatic cholestasis is defined by impaired bile flow without bile duct obstruction, leading to bile accumulation.
- It is associated with diverse causes like drugs, parenteral nutrition, sepsis, pregnancy, and systemic diseases.
Purpose of the Study:
- To review the characteristics, potential causes, and therapeutic strategies for intrahepatic cholestasis.
Main Methods:
- Literature review of intrahepatic cholestasis, focusing on etiology, pathogenesis, and treatment.
Main Results:
- The exact pathogenesis of intrahepatic cholestasis remains unclear despite various hypotheses.
- Ursodeoxycholic acid can alleviate symptoms like itching and fatigue and may influence disease progression.
- Supportive therapy is crucial for maintaining patient well-being when cholestasis persists.
Conclusions:
- While the pathophysiology of intrahepatic cholestasis is not fully understood, ursodeoxycholic acid offers symptomatic relief and potential disease modification.
- Liver transplantation represents the definitive treatment for end-stage liver disease resulting from intrahepatic cholestasis.